Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03017235 · ClinicalTrials.gov registry record · Phase 3
A Study Comparing the Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution With PREPOPIK® for Colon Cleansing in Preparation for Colonoscopy
A Phase 3 study, sponsored by Ferring Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 917
- Enrollment target
NCT03017235 is a Phase 3 study that has completed, run by Ferring Pharmaceuticals. The registered enrollment target is 917 participants.
The verdict
NCT03017235, a Phase 3 study, has completed, sponsored by Ferring Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 917 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution with PREPOPIK® for colon cleansing in adult subjects undergoing colonoscopy.
Interventions
- DRUG Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution
- DRUG Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 917 participants |
| Start Date | 2017-02-20 |
| Est. Completion | 2017-10-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03017235
The ClinicalTrials.gov registry entry for NCT03017235 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 917 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ferring Pharmaceuticals, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution is the first listed.
NCT03017235 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03017235 about?
NCT03017235 is a clinical study titled "A Study Comparing the Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution With PREPOPIK® for Colon Cleansing in Preparation for Colonoscopy". The purpose of this study is to compare the Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution with PREPOPIK® for colon cleansing in adult subjects undergoing colonoscopy.
What is the current status of trial NCT03017235?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 917 participants. The study started on 2017-02-20. Estimated completion is 2017-10-12.
What interventions are being tested in trial NCT03017235?
The interventions under investigation include: Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution (DRUG), Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Powder (DRUG).
Who is sponsoring clinical trial NCT03017235?
This trial is sponsored by Ferring Pharmaceuticals, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.